287 related articles for article (PubMed ID: 9299805)
1. Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?
Oei TP; Llamas M; Evans L
Behav Res Ther; 1997 Sep; 35(9):851-7. PubMed ID: 9299805
[TBL] [Abstract][Full Text] [Related]
2. Increased probability of remaining in remission from panic disorder with agoraphobia after drug treatment in patients who received concurrent cognitive-behavioural therapy: a follow-up study.
Biondi M; Picardi A
Psychother Psychosom; 2003; 72(1):34-42. PubMed ID: 12466636
[TBL] [Abstract][Full Text] [Related]
3. Cognitive and Guided Mastery Therapies for Panic Disorder with Agoraphobia: 18-Year Long-Term Outcome and Predictors of Long-Term Change.
Hoffart A; Hedley LM; Svanøe K; Sexton H
Clin Psychol Psychother; 2016; 23(1):1-13. PubMed ID: 25452222
[TBL] [Abstract][Full Text] [Related]
4. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series.
Otto MW; Pollack MH; Penava SJ; Zucker BG
Behav Res Ther; 1999 Aug; 37(8):763-70. PubMed ID: 10452176
[TBL] [Abstract][Full Text] [Related]
5. [JSNP Excellent Presentation Award for AsCNP 2011: an analysis of pharmacotherapy combined cognitive-behavioral group therapy for panic disorder with agoraphobia].
Takashio O; Kokubo Y; Akita R; Tanaka H; Sakagami K; Shimizu H; Okajima Y; Nakamura D; Akashi N; Kato N
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Apr; 32(2):105-7. PubMed ID: 22708267
[No Abstract] [Full Text] [Related]
6. A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia.
Cottraux J; Note ID; Cungi C; Légeron P; Heim F; Chneiweiss L; Bernard G; Bouvard M
Br J Psychiatry; 1995 Nov; 167(5):635-41. PubMed ID: 8564320
[TBL] [Abstract][Full Text] [Related]
7. Combined antidepressants and CBT for panic disorder with agoraphobia.
Coupland NJ
J Psychiatry Neurosci; 2008 Mar; 33(2):176. PubMed ID: 18330461
[No Abstract] [Full Text] [Related]
8. Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.
Loerch B; Graf-Morgenstern M; Hautzinger M; Schlegel S; Hain C; Sandmann J; Benkert O
Br J Psychiatry; 1999 Mar; 174():205-12. PubMed ID: 10448444
[TBL] [Abstract][Full Text] [Related]
9. Follow-up on the treatment of panic disorder with or without agoraphobia: a quantitative review.
Bakker A; van Balkom AJ; Spinhoven P; Blaauw BM; van Dyck R
J Nerv Ment Dis; 1998 Jul; 186(7):414-9. PubMed ID: 9680042
[TBL] [Abstract][Full Text] [Related]
10. Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder.
Nadiga DN; Hensley PL; Uhlenhuth EH
Depress Anxiety; 2003; 17(2):58-64. PubMed ID: 12621593
[TBL] [Abstract][Full Text] [Related]
11. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia.
Furukawa TA; Watanabe N; Churchill R
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD004364. PubMed ID: 17253502
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of agoraphobia with panic disorder.
Perugi G; Frare F; Toni C
CNS Drugs; 2007; 21(9):741-64. PubMed ID: 17696574
[TBL] [Abstract][Full Text] [Related]
13. Influence of personality disorder on the treatment of panic disorder--comparison study.
Prasko J; Houbová P; Novák T; Záleský R; Espa-Cervená K; Pasková B; Vyskocilová J
Neuro Endocrinol Lett; 2005 Dec; 26(6):667-74. PubMed ID: 16380683
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the cost and the effectiveness of a psychotherapy for panic disorder with agoraphobia (PDA) versus a treatment combining pharmacotherapy and psychotherapy].
Marchand A; Germain V; Reinharz D; Mainguy N; Landry P
Sante Ment Que; 2004; 29(2):201-20. PubMed ID: 15928793
[TBL] [Abstract][Full Text] [Related]
15. Effects of group experiential cognitive therapy for the treatment of panic disorder with agoraphobia.
Choi YH; Vincelli F; Riva G; Wiederhold BK; Lee JH; Park KH
Cyberpsychol Behav; 2005 Aug; 8(4):387-93. PubMed ID: 16092896
[TBL] [Abstract][Full Text] [Related]
16. Use of medical services and treatment for panic disorder with agoraphobia and for social phobia.
Swinson RP; Cox BJ; Woszczyna CB
CMAJ; 1992 Sep; 147(6):878-83. PubMed ID: 1525731
[TBL] [Abstract][Full Text] [Related]
17. Study and course of the psychological profile in 77 patients expressing panic disorder with agoraphobia after cognitive behaviour therapy with or without buspirone.
Bouvard M; Mollard E; Guerin J; Cottraux J
Psychother Psychosom; 1997; 66(1):27-32. PubMed ID: 8996712
[TBL] [Abstract][Full Text] [Related]
18. Depression, mastery and number of group sessions attended predict outcome of patients with panic and agoraphobia in a behavioural/medication program.
Bowen R; South M; Fischer D; Looman T
Can J Psychiatry; 1994 Jun; 39(5):283-8. PubMed ID: 8044744
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.
van Apeldoorn FJ; Timmerman ME; Mersch PP; van Hout WJ; Visser S; van Dyck R; den Boer JA
J Clin Psychiatry; 2010 May; 71(5):574-86. PubMed ID: 20492852
[TBL] [Abstract][Full Text] [Related]
20. [Tranylcypromine for chronic therapy-resistant agoraphobia with panic disorder and recurrent depressive disorder].
Boerner RJ; Lühring F
Psychiatr Prax; 2010 Oct; 37(7):350-2. PubMed ID: 20703987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
